Expert Interview
Discussing Agios Phase 3 RISE UP trial for Mitapivat, an oral, small molecule PK activator, in sickle cell disease patients
Ticker(s): AGIOInstitution: Virginia Commonwealth University
- The Florence Neal Cooper Smith Professor of Sickle Cell Disease at Virginia Commonwealth University (VCU)
- An experienced implementation scientist and an expert in clinical and health services research in sickle cell disease
- Manages 750 patients with sickle cell disease
- Investigator and ad board for the RISE-UP clinical trial of Mitapavit in patients with sickle cell disease
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
